Gasdermin A (GSDMA) Tissue Expression, Serum and Urinary Concentrations With Clinicopathologic Outcome in Psoriasis

Gasdermin A (GSDMA) Tissue Expression, Serum and Urinary Concentrations With Clinicopathologic Outcome in Psoriasis

Authors

  • Julia Nowowiejska Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland
  • Anna Baran Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland
  • Anna Pryczynicz Department of General Pathomorphology, Medical University of Bialystok, Bialystok, Poland
  • Justyna Hermanowicz Department of Pharmacodynamics, Medical University of Bialystok, Bialystok, Poland
  • Beata Sieklucka Department of Pharmacodynamics, Medical University of Bialystok, Bialystok, Poland
  • Dariusz Pawlak Department of Pharmacodynamics, Medical University of Bialystok, Bialystok, Poland
  • Iwona Flisiak Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland

Keywords:

gasdermin A, GSDMA, psoriasis, hyperkeratosis

Abstract

Introduction: Psoriasis is a frequent and incurable skin disease that is an important issue in contemporary dermatology, whereas its pathogenesis is still uncertain. Gasdermin A (GSDMA) is a member of the gasdermin protein family that enables pore formation in cellular membranes leading to cell death called pyroptosis.

Objective: Our aim was to investigate the role of GSDMA in psoriatic patients.

Method: The study enrolled 60 patients with active plaque-type psoriasis and 30 sex- and age-matched volunteers without dermatoses. GSDMA concentration was assessed in serum and urine samples of all participants using ELISA. GSDMA tissue expression was assessed by immunohistochemistry.

Results: GSDMA serum concentration was significantly higher in patients compared to controls, whereas urinary GSDMA/creatinine ratio was insignificantly lower. GSDMA tissue expression was more prominent in psoriatic plaque compared to non-lesional patient skin and healthy skin of subjects without dermatoses. There was a strong negative correlation between GSDMA serum concentration and alanine aminotransferase (ALT) activity. GSDMA did not correlate with PASI or psoriasis duration.

Conclusions: Obtained results point to the probable involvement of GSDMA in psoriasis. GSDMA overexpression may probably lead to keratinocytes hyperproliferation and be responsible for triggering inflammation in psoriatic skin. Serum GSDMA, but not urinary GSDMA, could become psoriasis biomarker.

References

. Farley E, Menter A. Psoriasis: Comorbidities and associations. G. Ital. Dermatol. Veneorol. 2011; 146:9–15.

Hirotsu C, Rydlewski M., Araújo MS. et al. Sleep loss and cytokines levels in an experimental model of psoriasis. PLoS ONE 2012; 7:e51183.

Lanna C, Mancini M, Gaziano R. et al. Skin immunity and its dysregulation in psoriasis. Cell Cycle 2019; 18: 2581-2589.

Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. (2019) 20:1475.

Nabieva K, Vender R. Quality of Life and Body Region Affected by Psoriasis: A Systematic Review. Actas Dermosifiliogr. 2023; 114:33-38.

Saeki H, Kanai Y, Murotani K, Ito K, Miyagi T, Takahashi H, Tada Y, Higashiyama M, Hashimoto Y, Kitabayashi H, Imafuku S. Work productivity in real-life employed patients with plaque psoriasis: Results from the ProLOGUE study. J Dermatol. 2022; 49:970-978.

Information about psoriasis, available at: https://www.psoriasis.org/about-psoriasis/ accessed on August 7th 2023.

Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020; 323:1945-1960.

Rogers C, Alnemri ES. Gasdermins in Apoptosis: New players in an Old Game. Yale J Biol Med. 2019; 92:603-617.

Kovacs SB, Miao EA. Gasdermins: Effectors of Pyroptosis. Trends Cell Biol. 2017; 27:673-684.

Zou J, Zheng Y, Huang Y, Tang D, Kang R, Chen R. The Versatile Gasdermin Family: Their Function and Roles in Diseases. Front Immunol. 2021; 12:751533.

Kuc-Ciepluch D, Ciepluch K, Arabski M. Gasdermin family proteins as a permeabilization factor of cell membrane in pyroptosis process. Postepy Hig Med Dosw 2021; 75:337-344.

Lunny DP, Weed E, Nolan PM, Marquardt A, Augustin M, Porter RM. Mutations in gasdermin 3 cause aberrant differentiation of the hair follicle and sebaceous gland. J Invest Dermatol. 2005; 124:615-21.

Liu X, Xia S, Zhang Z, Wu H, Lieberman J. Channelling inflammation: gasdermins in physiology and disease. Nat Rev Drug Discov. 2021; 20:384-405.

Li L, Kovacs SB, Jørgensen I, Larson HN, Lazear HM, Miao EA. Role of Caspases and Gasdermin A during HSV-1 Infection in Mice. Viruses. 2022; 14:2034.

Deng W, Bai Y, Deng F, Pan Y, Mei S, Zheng Z, Min R, Wu Z, Li W, Miao R, Zhang Z, Kupper TS, Lieberman J, Liu X. Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis. Nature. 2022; 602:496-502.

Söderman J, Berglind L, Almer S. Gene Expression-Genotype Analysis Implicates GSDMA, GSDMB, and LRRC3C as Contributors to Inflammatory Bowel Disease Susceptibility. Biomed Res Int. 2015; 2015:834805.

Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y. Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis. Ann Rheum Dis. 2017; 76:1150-1158.

Yu J, Kang MJ, Kim BJ, Kwon JW, Song YH, Choi WA, Shin YJ, Hong SJ. Polymorphisms in GSDMA and GSDMB are associated with asthma susceptibility, atopy and BHR. Pediatr Pulmonol. 2011; 46:701-8.

Lin HY, Lin PH, Wu SH, Yang LT. Inducible expression of gasdermin A3 in the epidermis causes epidermal hyperplasia and skin inflammation. Exp Dermatol. 2015; 24:897-9.

Tanaka S, Mizushina Y, Kato Y, Tamura M, Shiroishi T. Functional conservation of Gsdma cluster genes specifically duplicated in the mouse genome. G3 (Bethesda). 2013; 3:1843-50.

Huang LY, Li ST, Lin SC, Kao CH, Hong CH, Lee CH, Yang LT. Gasdermin A Is Required for Epidermal Cornification during Skin Barrier Regeneration and in an Atopic Dermatitis-like Model. J Invest Dermatol. 2023; S0022-202X(23)01938-3.

Flisiak I, Porebski P, Flisiak R, Chodynicka B. Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy. Biomarkers. 2003; 8:437–443.

Flisiak I, Chodynicka B, Porebski P, Flisiak R. Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions. Cytokine. 2002; 19:121–125.

Dobrică EC, Cozma MA, Găman MA, Voiculescu VM, Găman AM. The Involvement of Oxidative Stress in Psoriasis: A Systematic Review. Antioxidants (Basel). 2022; 11:282.

Wang Z, Zhou H, Zheng H, Zhou X, Shen G, Teng X, Liu X, Zhang J, Wei X, Hu Z, Zeng F, Hu Y, Hu J, Wang X, Chen S, Cheng J, Zhang C, Gui Y, Zou S, Hao Y, Zhao Q, Wu W, Zhou Y, Cui K, Huang N, Wei Y, Li W, Li J. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation. Autophagy. 2021; 17:529-552.

Wu DJ, Adamopoulos IE. Autophagy and autoimmunity. Clin Immunol. 2017; 176:55-62.

Zhang, D., Li, Y., Du, C. et al. Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level. J Transl Med 2022; 20:363.

Knorr J, Wree A, Feldstein AE. Pyroptosis in Steatohepatitis and Liver Diseases. J Mol Biol. 2022; 434:167271.

Wang J, Huang Z, Lu H, Zhang R, Feng Q, He A. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma. Comput Math Methods Med. 2022; 2022:1258480.

Downloads

Published

2024-07-31

How to Cite

1.
Gasdermin A (GSDMA) Tissue Expression, Serum and Urinary Concentrations With Clinicopathologic Outcome in Psoriasis. Dermatol Pract Concept [Internet]. 2024 Jul. 31 [cited 2024 Dec. 5];14(3):e2024177. Available from: https://www.dpcj.org/index.php/dpc/article/view/4137

Share